UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 302

Sortiert nach

Determinants of Antiviral Effectiveness in Influenza Virus A Subtype H5N1

The Journal of infectious diseases, 2012-11, Vol.206 (9), p.1359-1366

2012

Volltextzugriff (PDF)

COVID-19 Vaccination Breakthrough Infections in a Real-World Setting: Using Community Reporters to Evaluate Vaccine Effectiveness [Corrigendum]

Infection and drug resistance, 2022-09, Vol.15, p.5543-5544

2022

Volltextzugriff (PDF)

Pharmacokinetic-Pharmacodynamic Determinants of Oseltamivir Efficacy Using Data from Phase 2 Inoculation Studies

Antimicrobial Agents and Chemotherapy, 2013-08, Vol.57 (8), p.3478-3487

2013

Volltextzugriff (PDF)

Previously diagnosed influenza infections and the risk of developing epilepsy

Epidemiology and infection, 2015-08, Vol.143 (11), p.2408-2415

2015

Volltextzugriff (PDF)

Cost-utility analysis of antiviral use under pandemic influenza using a novel approach - linking pharmacology, epidemiology and heath economics

Epidemiology and infection, 2018-03, Vol.146 (4), p.496-507

2018

Volltextzugriff (PDF)

Safety of Artemisinin Antimalarials

Clinical infectious diseases, 2006-04, Vol.42 (8), p.1214-1215

Toovey, Stephen

2006

Volltextzugriff (PDF)

Effectiveness of co-artemether in an unsupervised outpatient setting for the treatment of falciparum malaria

Travel medicine and infectious disease, 2008, Vol.6 (1), p.29-31

Toovey, S

2008

Volltextzugriff (PDF)

Cost-Utility Analysis of Optimal Dosing of Oseltamivir Under Pandemic Influenza Using a Novel Approach: Linking Health Economics and Transmission Dynamic Models

Value in health, 2014-11, Vol.17 (7), p.A807-A807

2014

Volltextzugriff (PDF)

Malaria swings, HIV roundabouts

Travel medicine and infectious disease, 2004-05, Vol.2 (2), p.99-105

Toovey, S.

2004

Volltextzugriff (PDF)

Co-artemether has been used in ambulatory treatment of falciparum malaria

BMJ (Online), 2002-06, Vol.324 (7353), p.1585

International edition, 2002

Volltextzugriff (PDF)

Tourists travelling to Kilimanjaro do need advice

BMJ (Online), 2002-07, Vol.325 (7354), p.46

International edition, 2002

Volltextzugriff (PDF)

Malaria: current prophylaxis options

South African family practice, 2004-10, Vol.46 (9), p.43-45

Toovey, S

2004

Volltextzugriff (PDF)

Evaluation of the QT effect of a combination of piperaquine and a novel anti‐malarial drug candidate OZ439, for the treatment of uncomplicated malaria

British journal of clinical pharmacology, 2015-10, Vol.80 (4), p.706-715

2015

Volltextzugriff (PDF)

COVID-19 Vaccination Breakthrough Infections in a Real-World Setting: Using Community Reporters to Evaluate Vaccine Effectiveness

Infection and drug resistance, 2022-09, Vol.15, p.5167-5182

2022

Volltextzugriff (PDF)

Identification of a Vulnerable Group for Post-Acute Sequelae of SARS-CoV-2 (PASC): People with Autoimmune Diseases Recover More Slowly from COVID-19

International journal of general medicine, 2021-01, Vol.14, p.3941-3949

2021

Volltextzugriff (PDF)

Audiometric changes associated with the treatment of uncomplicated falciparum malaria with co-artemether

Transactions of the Royal Society of Tropical Medicine and Hygiene, 2004-05, Vol.98 (5), p.261-267

2004

Volltextzugriff (PDF)

Are currently deployed artemisinins neurotoxic? Reply to Adjei et al

Toxicology letters, 2006-12, Vol.167 (2), p.165-166

Toovey, S.

2006

Volltextzugriff (PDF)

Multilayered: Engineered Variety

1st edition., 2019

Volltextzugriff (PDF)

Artesunate versus quinine for severe falciparum malaria

The Lancet (British edition), 2006-01, Vol.367 (9505), p.111-111

Toovey, Stephen

2006

Volltextzugriff (PDF)

Pancreatitis complicating adult immunisation with a combined mumps measles rubella vaccine. A case report and literature review

Travel medicine and infectious disease, 2003-08, Vol.1 (3), p.189-192

2003

Volltextzugriff (PDF)

Falciparum malaria presenting with pruritic rashes

Travel medicine and infectious disease, 2004-08, Vol.2 (3), p.189-191

2004

Volltextzugriff (PDF)

Successful co-artemether (artemether–lumefantrine) clearance of falciparum malaria in a patient with severe cholera in Mozambique

Travel medicine and infectious disease, 2003-08, Vol.1 (3), p.177-179

2003

Volltextzugriff (PDF)

Haemoglobinuria in a case of Falciparum malaria treated with co-artemether

Travel medicine and infectious disease, 2003-02, Vol.1 (1), p.45-46

2003

Volltextzugriff (PDF)

H5N1 Avian Influenza in Children

Clinical infectious diseases, 2012-07, Vol.55 (1), p.26-32

2012

Volltextzugriff (PDF)

Reply to comment on: Audiometric changes associated with the treatment of uncomplicated falciparum malaria with co-artemether

Transactions of the Royal Society of Tropical Medicine and Hygiene, 2005-04, Vol.99 (4), p.314-315

Toovey, Stephen

2005

Volltextzugriff (PDF)

1 – 25 von 302

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(239)
Mit Volltextzugriff
(233)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(140)
Life Sciences & Biomedicine
(135)
Humans
(100)
Infectious Diseases
(50)
Female
(48)
Male
(43)
Travel Medicine
(41)
Malaria
(35)
Adult
(34)
Animals
(33)
Public, Environmental & Occupational Health
(30)
Child
(27)
Adolescent
(26)
Infectious Disease
(25)
Middle Aged
(25)
Travel
(25)
Biological And Medical Sciences
(23)
Aged
(20)
Influenza
(20)
General & Internal Medicine
(19)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Determinants of Antiviral Effectiveness in Influenza Virus A Subtype H5N1

COVID-19 Vaccination Breakthrough Infections in a Real-World Setting: Using Community Reporters to Evaluate Vaccine Effectiveness [Corrigendum]

Pharmacokinetic-Pharmacodynamic Determinants of Oseltamivir Efficacy Using Data from Phase 2 Inoculation Studies

Previously diagnosed influenza infections and the risk of developing epilepsy

Cost-utility analysis of antiviral use under pandemic influenza using a novel approach - linking pharmacology, epidemiology and heath economics

Safety of Artemisinin Antimalarials

Effectiveness of co-artemether in an unsupervised outpatient setting for the treatment of falciparum malaria

Cost-Utility Analysis of Optimal Dosing of Oseltamivir Under Pandemic Influenza Using a Novel Approach: Linking Health Economics and Transmission Dynamic Models

Malaria swings, HIV roundabouts

Co-artemether has been used in ambulatory treatment of falciparum malaria

Tourists travelling to Kilimanjaro do need advice

Malaria: current prophylaxis options

Evaluation of the QT effect of a combination of piperaquine and a novel anti‐malarial drug candidate OZ439, for the treatment of uncomplicated malaria

COVID-19 Vaccination Breakthrough Infections in a Real-World Setting: Using Community Reporters to Evaluate Vaccine Effectiveness

Identification of a Vulnerable Group for Post-Acute Sequelae of SARS-CoV-2 (PASC): People with Autoimmune Diseases Recover More Slowly from COVID-19

Audiometric changes associated with the treatment of uncomplicated falciparum malaria with co-artemether

Are currently deployed artemisinins neurotoxic? Reply to Adjei et al

Multilayered: Engineered Variety

Artesunate versus quinine for severe falciparum malaria

Pancreatitis complicating adult immunisation with a combined mumps measles rubella vaccine. A case report and literature review

Falciparum malaria presenting with pruritic rashes

Successful co-artemether (artemether–lumefantrine) clearance of falciparum malaria in a patient with severe cholera in Mozambique

Haemoglobinuria in a case of Falciparum malaria treated with co-artemether

H5N1 Avian Influenza in Children

Reply to comment on: Audiometric changes associated with the treatment of uncomplicated falciparum malaria with co-artemether

Suchergebnisse filtern